TNFRSF12A and Meniere disease: Our current findings suggest that studying this pathway could represent a new research direction, especially given recent studies identifying the TWEAK/Fn14 pathway as a top candidate pathway involved in the modulation of inflammation in Meniere’s disease based on immune genotyping [72], and TWEAK’s ability to impair synaptic transmission and plasticity [73].